Business

February 3, 2014 6:29 PM

Cornerstone shareholders approve Chiesi merger

Cornerstone Therapeutics stockholders approved the Cary drug developer’s merger with Italy’s Chiesi Farmaceutici on Monday.

Related content

Comments